Current Status of Liver Transplantation in North America

Hassan Aziz; Paramita Nayak; David C Mulligan

doi:10.1016/j.suc.2023.08.002

Current Status of Liver Transplantation in North America

Surg Clin North Am. 2024 Feb;104(1):1-9. doi: 10.1016/j.suc.2023.08.002. Epub 2023 Sep 9.

Authors

Hassan Aziz¹, Paramita Nayak¹, David C Mulligan²

Affiliations

¹ Division of Transplant and Hepatobiliary Surgery, University of Iowa Hospital and Clinics, Iowa City, IA, USA.
² Division of Transplantation and Immunology, Transplant Innovation and Technology, Department of Surgery, UNOS/OPTN, Yale-New Haven Health Transplantation Center, Yale University School of Medicine, 333 Cedar Street, Farnum Medical Building Room 121, New Haven, CT 06520, USA. Electronic address: david.mulligan@yale.edu.

PMID: 37953028
DOI: 10.1016/j.suc.2023.08.002

Abstract

Liver transplantation indications continue to evolve in North America. Several recent changes have occurred in the field with changes in the allocation system, new performance metrics, expansion of transplant oncology, and utilization of ex vivo perfusion devices and techniques. Deceased donor liver transplantation continues to be the primary modality of liver transplantation in North America, with an ongoing focus on advancing the use of living donor liver transplantation, especially in those patients who may not have favorable access to deceased donor allografts.

Keywords: Liver transplantation; Machine perfusion; Transplant oncology.

Publication types

Review

MeSH terms

Humans
Liver
Liver Transplantation* / methods
Living Donors
North America